Kestra Medical Technologies Ltd expected to post a loss of 52 cents a share - Earnings Preview

Kestra Medical Technologies

11/07/2025 21:02

Kestra Medical Technologies Ltd KMTS.OQ KMTS.O is expected to report resultson July 15 for the period ending April 30 2025

The Kirkland Washington-based  company is expected to report revenue of $15.752 million, according to the mean estimate from 6 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Kestra Medical Technologies Ltd is for a loss of 52 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The average consensus recommendation for the advanced medical equipment & technology peer group is also "Buy".​

Wall Street's median 12-month price target for Kestra Medical Technologies Ltd is $28.00, about 45.8% above its last closing price of $15.19

This summary was machine generated July 11 at 20:01 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)